Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients
Clinical trial NCT01791491 · COMPLETED
Trial details
- NCT number
- NCT01791491
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-09
- Primary completion
- 2016-12-06
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.